These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 11236100)

  • 1. The stability between two HIV-1 RNA measurements one year apart and the relationship with HIV subtype in rural Uganda.
    Morgan D; Kaleebu P; Whitworth J; Yirrell D; Rutebemberwa A; Shier R; Sebabi B; Gilmour J; Eotu H; Omoding N; Gotch F
    Int J STD AIDS; 2001 Feb; 12(2):116-21. PubMed ID: 11236100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load.
    Gottesman BS; Grosman Z; Lorber M; Levi I; Shitrit P; Mileguir F; Gottesman G; Chowers MY
    J Med Virol; 2004 Jun; 73(2):167-71. PubMed ID: 15122788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 RNA levels in an African population-based cohort and their relation to CD4 lymphocyte counts and World Health Organization clinical staging.
    Morgan D; Rutebemberwa A; Malamba S; Ross A; Whitworth J; Kaleebu P; Gotch F
    J Acquir Immune Defic Syndr; 1999 Oct; 22(2):167-73. PubMed ID: 10843531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of HIV-1 subtypes on disease progression in rural Uganda: a prospective clinical cohort study.
    Ssemwanga D; Nsubuga RN; Mayanja BN; Lyagoba F; Magambo B; Yirrell D; Van der Paal L; Grosskurth H; Kaleebu P
    PLoS One; 2013; 8(8):e71768. PubMed ID: 23951241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtype-specific problems with quantification of plasma HIV-1 RNA.
    Alaeus A; Lidman K; Sönnerborg A; Albert J
    AIDS; 1997 Jun; 11(7):859-65. PubMed ID: 9189210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort.
    Kaleebu P; Ross A; Morgan D; Yirrell D; Oram J; Rutebemberwa A; Lyagoba F; Hamilton L; Biryahwaho B; Whitworth J
    AIDS; 2001 Feb; 15(3):293-9. PubMed ID: 11273208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa.
    Stevens G; Rekhviashvili N; Scott LE; Gonin R; Stevens W
    J Clin Microbiol; 2005 Feb; 43(2):857-61. PubMed ID: 15695692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
    Pan P; Tao X; Zhang Q; Xing W; Sun X; Pei L; Jiang Y
    AIDS; 2007 Dec; 21 Suppl 8():S27-32. PubMed ID: 18172387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation Levels.
    Eller MA; Opollo MS; Liu M; Redd AD; Eller LA; Kityo C; Kayiwa J; Laeyendecker O; Wawer MJ; Milazzo M; Kiwanuka N; Gray RH; Serwadda D; Sewankambo NK; Quinn TC; Michael NL; Wabwire-Mangen F; Sandberg JK; Robb ML
    J Infect Dis; 2015 May; 211(10):1574-84. PubMed ID: 25404522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative performance of the Amplicor HIV-1 Monitor Assay versus NucliSens EasyQ in HIV subtype C-infected patients.
    Gottesman BS; Grossman Z; Lorber M; Levi I; Shitrit P; Katzir M; Shahar E; Gottesman G; Chowers M
    J Med Virol; 2006 Jul; 78(7):883-7. PubMed ID: 16721845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
    AIDS; 1998 Mar; 12(4):F1-8. PubMed ID: 9520161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of human immunodeficiency virus-1 viral load using nucleic acid sequence-based amplification (NASBA) in north central Nigeria.
    Forbi JC; Gabadi S; Iperepolu HO; Esona MD; Agwale SM
    Niger J Clin Pract; 2010 Sep; 13(3):284-7. PubMed ID: 20857786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of HIV-1 non-B subtype infections in Northwest Poland.
    Parczewski M; Leszczyszyn-Pynka M; Bander D; Urbańska A; Stańczak G; Boroń-Kaczmarska A
    J Med Virol; 2010 Aug; 82(8):1306-13. PubMed ID: 20578066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda.
    Kiwanuka N; Robb M; Laeyendecker O; Kigozi G; Wabwire-Mangen F; Makumbi FE; Nalugoda F; Kagaayi J; Eller M; Eller LA; Serwadda D; Sewankambo NK; Reynolds SJ; Quinn TC; Gray RH; Wawer MJ; Whalen CC
    J Acquir Immune Defic Syndr; 2010 Jun; 54(2):180-4. PubMed ID: 20010433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa.
    Gray CM; Williamson C; Bredell H; Puren A; Xia X; Filter R; Zijenah L; Cao H; Morris L; Vardas E; Colvin M; Gray G; McIntyre J; Musonda R; Allen S; Katzenstein D; Mbizo M; Kumwenda N; Taha T; Karim SA; Flores J; Sheppard HW
    AIDS Res Hum Retroviruses; 2005 Apr; 21(4):285-91. PubMed ID: 15943570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.
    Mermin J; Lule J; Ekwaru JP; Malamba S; Downing R; Ransom R; Kaharuza F; Culver D; Kizito F; Bunnell R; Kigozi A; Nakanjako D; Wafula W; Quick R
    Lancet; 2004 Oct 16-22; 364(9443):1428-34. PubMed ID: 15488218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the NucliSens EasyQ HIV-1 v1.1 and RealTime HIV-1 kits for quantitation of HIV-1 RNA in plasma.
    Choi JY; Kim EJ; Rho HJ; Kim JY; Kwon OK; Lee JH; Koo MJ; Kim SS
    J Virol Methods; 2009 Oct; 161(1):7-11. PubMed ID: 19576640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda.
    Kipp W; Alibhai A; Saunders LD; Senthilselvan A; Kaler A; Konde-Lule J; Okech-Ojony J; Rubaale T
    AIDS Care; 2010 Mar; 22(3):271-8. PubMed ID: 20390506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study.
    Whitworth J; Morgan D; Quigley M; Smith A; Mayanja B; Eotu H; Omoding N; Okongo M; Malamba S; Ojwiya A
    Lancet; 2000 Sep; 356(9235):1051-6. PubMed ID: 11009139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Coste J; Montes B; Reynes J; Peeters M; Segarra C; Vendrell JP; Delaporte E; Segondy M
    J Med Virol; 1996 Dec; 50(4):293-302. PubMed ID: 8950685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.